Skip to main content

Perspective Therapeutics, Inc.

CATX
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0000728387

In the last 90 days, Perspective Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 131 institutions reported holding it in 13F filings for Q2 2026, worth $297.6M in total; no superinvestor holds it.

13F holders, Q1 2025

Institutional positions in Perspective Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
112
−22 vs. Q4 2024
Shares held
45.3M
−1.26M (−2.7%) vs. Q4 2024
Total value
$96.4M
−$52.0M (−35.0%) vs. Q4 2024
New holders
14
34 more added
Sold out
36
39 more reduced

1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CATX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 112 institutions
Q1 2021: 57 institutionsQ2 2021: 48 institutionsQ3 2021: 43 institutionsQ4 2021: 45 institutionsQ1 2022: 39 institutionsQ2 2022: 43 institutionsQ3 2022: 35 institutionsQ4 2022: 48 institutionsQ1 2023: 42 institutionsQ2 2023: 50 institutionsQ3 2023: 49 institutionsQ4 2023: 52 institutionsQ1 2024: 104 institutionsQ2 2024: 105 institutionsQ3 2024: 127 institutionsQ4 2024: 135 institutionsQ1 2025: 112 institutionsQ2 2025: 98 institutionsQ3 2025: 105 institutionsQ4 2025: 117 institutionsQ1 2026: 138 institutionsQ2 2026: 131 institutions
Value heldQ1 2025: $96.4M
Q1 2021: $20.2MQ2 2021: $13.9MQ3 2021: $9.99MQ4 2021: $6.78MQ1 2022: $5.79MQ2 2022: $5.19MQ3 2022: $3.70MQ4 2022: $4.26MQ1 2023: $17.8MQ2 2023: $22.0MQ3 2023: $9.99MQ4 2023: $14.7MQ1 2024: $294.6MQ2 2024: $384.9MQ3 2024: $654.9MQ4 2024: $150.7MQ1 2025: $96.4MQ2 2025: $146.3MQ3 2025: $150.1MQ4 2025: $105.0MQ1 2026: $333.1MQ2 2026: $297.6M
Institutions holding CATX and their total value by quarter
QuarterHoldersValue
Q2 2026131$297.6M
Q1 2026138$333.1M
Q4 2025117$105.0M
Q3 2025105$150.1M
Q2 202598$146.3M
Q1 2025112$96.4M
Q4 2024135$150.7M
Q3 2024127$654.9M
Q2 2024105$384.9M
Q1 2024104$294.6M
Q4 202352$14.7M
Q3 202349$9.99M
Q2 202350$22.0M
Q1 202342$17.8M
Q4 202248$4.26M
Q3 202235$3.70M
Q2 202243$5.19M
Q1 202239$5.79M
Q4 202145$6.78M
Q3 202143$9.99M
Q2 202148$13.9M
Q1 202157$20.2M

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding Perspective Therapeutics, Inc.; share changes are against Q4 2024.

Institutions holding CATX in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Marshall Wace, LLP1,135,445$2.42M0.00%+328,273+40.7%Added
Geode Capital Management, LLC1,193,927$2.54M0.00%+26,499+2.3%Added
Nuveen, LLC1,242,542$2.65M0.00%+1,242,542New
Morgan Stanley1,558,451$3.32M0.00%+414,989+36.3%Added
Nicholson Wealth Management Group, LLC1,609,283$3.43M2.25%00.0%Unchanged
Avidity Partners Management LP2,197,270$4.68M0.97%−497,330−18.5%Reduced
Affinity Asset Advisors, LLC2,224,196$4.74M0.74%+924,196+71.1%Added
Octagon Capital Advisors LP2,250,000$4.79M1.04%−54,752−2.4%Reduced
Deerfield Management Company, L.P. (Series C)2,829,413$6.03M0.12%−109,341−3.7%Reduced
Vanguard Group Inc3,067,051$6.53M0.00%−77,816−2.5%Reduced
BlackRock, Inc.3,971,525$8.46M0.00%−133,722−3.3%Reduced
FMR LLC10,050,739$21.4M0.00%+23,438+0.2%Added
Perceptive Advisors LLC0$00.00%−1,190,263−100.0%Sold out
Jump Financial, LLC0$00.00%−215,725−100.0%Sold out
Schonfeld Strategic Advisors LLC0$00.00%−168,500−100.0%Sold out
Balyasny Asset Management LLC0$00.00%−130,914−100.0%Sold out
DAFNA Capital Management LLC0$00.00%−130,169−100.0%Sold out
Ikarian Capital, LLC0$00.00%−108,300−100.0%Sold out
Altium Capital Management LP0$00.00%−92,224−100.0%Sold out
Swiss National Bank0$00.00%−86,260−100.0%Sold out
UBS Asset Management Americas Inc0$00.00%−70,150−100.0%Sold out
Aristides Capital LLC0$00.00%−58,700−100.0%Sold out
Point72 Asset Management, L.P.0$00.00%−54,893−100.0%Sold out
Victory Capital Management Inc0$00.00%−49,420−100.0%Sold out
Freestone Grove Partners LP0$00.00%−47,386−100.0%Sold out
Mariner, LLC0$00.00%−46,900−100.0%Sold out
Arrowstreet Capital, Limited Partnership0$00.00%−36,752−100.0%Sold out
Aquatic Capital Management LLC0$00.00%−32,718−100.0%Sold out
Boothbay Fund Management, LLC0$00.00%−31,150−100.0%Sold out
Tudor Investment Corp Et Al0$00.00%−28,577−100.0%Sold out
Zurcher Kantonalbank (Zurich Cantonalbank)0$00.00%−26,591−100.0%Sold out
KLP Kapitalforvaltning AS0$00.00%−24,769−100.0%Sold out
Virtus ETF Advisers LLC0$00.00%−20,487−100.0%Sold out
Corton Capital Inc.0$00.00%−19,180−100.0%Sold out
XTX Topco Ltd0$00.00%−18,070−100.0%Sold out
Janus Henderson Group PLC0$00.00%−17,839−100.0%Sold out
Ameriprise Financial Inc0$00.00%−17,326−100.0%Sold out
Jain Global LLC0$00.00%−14,100−100.0%Sold out
Teacher Retirement System of Texas0$00.00%−13,220−100.0%Sold out
Arizona State Retirement System0$00.00%−12,720−100.0%Sold out
Los Angeles Capital Management LLC0$00.00%−11,424−100.0%Sold out
Aigen Investment Management, LP0$00.00%−10,522−100.0%Sold out
Y-Intercept (Hong Kong) Ltd0$00.00%−10,263−100.0%Sold out
R Squared Ltd0$00.00%−4,100−100.0%Sold out
US Bancorp0$00.00%−3,035−100.0%Sold out
Mendota Financial Group, LLC0$00.00%−1,750−100.0%Sold out
Public Employees Retirement Association of Colorado0$00.00%−498−100.0%Sold out
GAMMA Investing LLC0$00.00%−64−100.0%Sold out
Nuveen Asset Management, LLC––––Not filed